KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,392,719 | +2.4% | 1,577,956 | +18.8% | 0.00% | 0.0% |
| Q2 2023 | $14,051,474 | -10.7% | 1,328,116 | +3.2% | 0.00% | 0.0% |
| Q1 2023 | $15,734,392 | +103029.0% | 1,286,540 | +4.6% | 0.00% | 0.0% |
| Q4 2022 | $15,257 | -99.9% | 1,229,430 | +3.3% | 0.00% | 0.0% |
| Q3 2022 | $16,252,000 | -26.4% | 1,189,755 | -1.2% | 0.00% | -33.3% |
| Q2 2022 | $22,075,000 | +23.9% | 1,204,310 | +8.7% | 0.00% | +50.0% |
| Q1 2022 | $17,813,000 | +5.7% | 1,107,777 | -8.0% | 0.00% | 0.0% |
| Q4 2021 | $16,853,000 | -18.5% | 1,203,826 | +9.1% | 0.00% | -33.3% |
| Q3 2021 | $20,673,000 | -13.8% | 1,103,760 | -4.0% | 0.00% | 0.0% |
| Q2 2021 | $23,980,000 | -22.0% | 1,150,157 | +5.8% | 0.00% | -40.0% |
| Q1 2021 | $30,742,000 | -5.4% | 1,087,457 | +9.2% | 0.01% | 0.0% |
| Q4 2020 | $32,512,000 | +27.1% | 995,491 | +19.3% | 0.01% | 0.0% |
| Q3 2020 | $25,571,000 | +111.8% | 834,580 | +12.6% | 0.01% | +66.7% |
| Q2 2020 | $12,076,000 | +108.9% | 740,868 | +27.5% | 0.00% | +50.0% |
| Q1 2020 | $5,780,000 | -59.6% | 580,984 | -44.2% | 0.00% | +100.0% |
| Q4 2019 | $14,302,000 | +88.9% | 1,040,284 | +108.5% | 0.00% | -50.0% |
| Q3 2019 | $7,570,000 | -12.9% | 499,032 | +13.1% | 0.00% | 0.0% |
| Q2 2019 | $8,689,000 | +40.1% | 441,330 | +18.1% | 0.00% | 0.0% |
| Q1 2019 | $6,201,000 | -37.6% | 373,784 | -47.2% | 0.00% | 0.0% |
| Q4 2018 | $9,940,000 | +82.8% | 708,020 | +127.8% | 0.00% | 0.0% |
| Q3 2018 | $5,439,000 | +8.7% | 310,805 | +13.0% | 0.00% | 0.0% |
| Q2 2018 | $5,005,000 | +14.4% | 275,011 | +17.9% | 0.00% | +100.0% |
| Q1 2018 | $4,374,000 | +71.3% | 233,331 | +39.8% | 0.00% | 0.0% |
| Q4 2017 | $2,553,000 | +4.4% | 166,914 | +2.0% | 0.00% | 0.0% |
| Q3 2017 | $2,446,000 | +260.8% | 163,659 | +124.4% | 0.00% | – |
| Q2 2017 | $678,000 | +55.1% | 72,919 | +46.8% | 0.00% | – |
| Q1 2017 | $437,000 | +50.7% | 49,682 | +0.9% | 0.00% | – |
| Q4 2016 | $290,000 | -5.2% | 49,256 | +0.6% | 0.00% | – |
| Q3 2016 | $306,000 | – | 48,972 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |